Revvity
Amy Tolivaisa currently serves as the Sr. Manager of Global Marketing Communications for IDx at Revvity, Inc., a position held since September 2023 following the acquisition of Oxford Immunotec. From August 2015 to September 2023, Amy held multiple roles at Oxford Immunotec, progressing from Specialist to Sr. Manager in Marketing Communications. Prior experience includes positions at GateHouse Media from August 2012 to August 2015, where Amy worked as a Digital Specialist and in various marketing coordination roles. Amy holds a Bachelor of Science degree in Marketing from the University of Massachusetts Dartmouth, completed in 2012.
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com